Literature DB >> 25909279

Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.

Daniel E Beck1, Monica Abdelmalak2, Wei Lv1, P V Narasimha Reddy1, Gabrielle S Tender2, Elizaveta O'Neill1, Keli Agama2, Christophe Marchand2, Yves Pommier2, Mark Cushman1.   

Abstract

3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25909279      PMCID: PMC7753975          DOI: 10.1021/acs.jmedchem.5b00303

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  54 in total

1.  Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity.

Authors:  Smitha Antony; Keli K Agama; Ze-Hong Miao; Melinda Hollingshead; Susan L Holbeck; Mollie H Wright; Lyuba Varticovski; Muthukaman Nagarajan; Andrew Morrell; Mark Cushman; Yves Pommier
Journal:  Mol Pharmacol       Date:  2006-06-23       Impact factor: 4.436

Review 2.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

3.  Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes.

Authors:  Rui Gao; Shar-yin N Huang; Christophe Marchand; Yves Pommier
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 4.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

5.  Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.

Authors:  Muthukaman Nagarajan; Andrew Morrell; Alexandra Ioanoviciu; Smitha Antony; Glenda Kohlhagen; Keli Agama; Melinda Hollingshead; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

6.  Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: versatile intermediates for the design and synthesis of topoisomerase I inhibitors.

Authors:  Andrew Morrell; Smitha Antony; Glenda Kohlhagen; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem Lett       Date:  2006-01-25       Impact factor: 2.823

Review 7.  Interfacial inhibitors: targeting macromolecular complexes.

Authors:  Yves Pommier; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

8.  Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.

Authors:  Smitha Antony; Muthusamy Jayaraman; Gary Laco; Glenda Kohlhagen; Kurt W Kohn; Mark Cushman; Yves Pommier
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

9.  4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.

Authors:  Thomas S Dexheimer; Lalji K Gediya; Andrew G Stephen; Iwona Weidlich; Smitha Antony; Christophe Marchand; Heidrun Interthal; Marc Nicklaus; Robert J Fisher; Vincent C Njar; Yves Pommier
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

10.  Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.

Authors:  Peng-Cheng Lv; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2014-05-06       Impact factor: 7.446

View more
  5 in total

1.  Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.

Authors:  Daniel E Beck; Wei Lv; Monica Abdelmalak; Caroline B Plescia; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2016-02-09       Impact factor: 3.641

2.  Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.

Authors:  Mohamed S A Elsayed; Yafan Su; Ping Wang; Taresh Sethi; Keli Agama; Azhar Ravji; Christophe E Redon; Evgeny Kiselev; Katharine A Horzmann; Jennifer L Freeman; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2017-06-28       Impact factor: 7.446

3.  Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

Authors:  Daniel E Beck; P V Narasimha Reddy; Wei Lv; Monica Abdelmalak; Gabrielle S Tender; Sophia Lopez; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2016-04-12       Impact factor: 7.446

4.  Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage.

Authors:  Wuli Zhao; Caixia Zhang; Chongwen Bi; Cheng Ye; Danqing Song; Xiujun Liu; Rongguang Shao
Journal:  Onco Targets Ther       Date:  2016-05-11       Impact factor: 4.147

5.  The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation.

Authors:  Wuli Zhao; Guohua Jiang; Chongwen Bi; Yangbiao Li; Jingbo Liu; Cheng Ye; Hongwei He; Liang Li; Danqing Song; Rongguang Shao
Journal:  Oncotarget       Date:  2015-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.